Search
for
Sort by
Research 30 of 1000+
- Efficacy of Oral Apremilast in The Treatment of Alopecia Areata, at The Tertiary Care Hospital, Karachi
- Comparing the efficacy of oral apremilast, intralesional corticosteroids, and their combination in patients with patchy alopecia areata: a randomized clinical controlled trial
- Apremilast for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Case Series
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- An Updated in the Management of Alopecia Areata
- Primary cicatricial alopecia
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Apremilast is efficacious in refractory alopecia areata
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Sequential small-molecule therapy for lymphocytic cicatricial alopecia: A multicenter prospective cohort pilot study
- Novel investigational drugs for alopecia areata and future perspectives
- "Oral PEY Treatment Induces Hair Regrowth and Improves Hair Quality in Patients with Alopecia"
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Management of congenital ichthyoses: European guidelines of care, part two
- Systemic treatments for alopecia areata: A systematic review
- Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders
- Comment on ‘Androgenetic alopecia is associated with increased scalp hardness’: role of phosphodiesterase inhibitors?
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Novel therapies for alopecia areata: The era of rational drug development
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Alopecia areata – Current understanding and management
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement